Browsing Journal Reviews by Subject "Imatinib, CML, Cytopenia, Philadelphia, BCR-ABL, Tyrosine Kinase"
Now showing items 1-1 of 1
-
Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study
(University of Nairobi, 2022)Background Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline ...